000	00000cam 2200000zi 4500
001	9.965455
003	CaOODSP
005	20260924144511
006	m     o  d f
007	cr cn|||||||||
008	250826s2025    onca    os   f000 0 eng d
040	|aCaOODSP|beng|erda|cCaOODSP
041	0 |aeng|afre
045	|ay2y2
086	1 |aH82-68/2025-PDF
100	1 |aO'Shea, Brian, |eauthor.
245	10|aTrends in the global drug development pipeline, 2021-2025 = |bTendances concernant les médicaments émergents en développement à l'échelle mondiale, 2021-2025 / |cBrian O'Shea.
246	11|aTendances concernant les médicaments émergents en développement à l'échelle mondiale, 2021-2025
264	1|a[Ottawa] : |bPatented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, |c[2025]
300	|a1 online resource (1 page) : |bcolour illustrations
336	|atext|btxt|2rdacontent
337	|acomputer|bc|2rdamedia
338	|aonline resource|bcr|2rdacarrier
500	|a"NPDUIS, National Prescription Drug Utilization Information System."
520	|a"The pharmaceutical industry invests heavily in new drug development to bring innovative therapies to markets around the world. Studying the research and development pipeline, especially in the later stages, provides insight into the novel therapies that will shape the pharmaceutical landscape in the near future. This study presents a snapshot of the global pipeline and a breakdown of the various therapies undergoing clinical evaluation, as well as a look at the most notable drug development trends from 2021-2025"--Objective.
546	|aText in English and French.
650	0|aDrug development|vStatistics.
655	7|aStatistics|2lcgft
710	1 |aCanada. |bPatented Medicine Prices Review Board, |eissuing body.
788	|tTrends in the global drug development pipeline, 2021-2025 = |efre|w(CaOODSP)9.966237
856	40|qPDF|s390 KB|uhttps://publications.gc.ca/collections/collection_2026/cepmb-pmprb/H82-68-2025.pdf
856	4 |qHTML|sN/A|uhttps://www.canada.ca/en/patented-medicine-prices-review/services/npduis/analytical-studies/posters/trends-pipeline-2025poster.html